Ascendis Pharma A/S
ASND
Κατάταξη σε μετοχές
#1499
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Τιμή μετοχής
$234.36
Κεφαλαιοποίηση
$14.62B
Αλλαγή (1 ημέρα)
1.92%
Αλλαγή (1 έτος)
14.20%
Χώρα
DK
Εμπόριο Ascendis Pharma A/S (ASND)
Κατηγορία
Healthcare
Δείκτης P/S για Ascendis Pharma A/S (ASND)
Δείκτης P/S στις October 2026 TTM: 11.93
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Ascendis Pharma A/S, ο τρέχων δείκτης P/S (TTM) είναι 11.93. Στο τέλος του 2023, ο δείκτης ήταν 24.05.
Ιστορικό P/S για την Ascendis Pharma A/S από 2011 έως 2026
Δείκτης P/S στο τέλος κάθε έτους
| Έτος | P/S Ratio | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 11.93 | -43.64% |
| 2024 | 21.17 | -11.98% |
| 2023 | 24.05 | -80.76% |
| 2022 | 124.97 | -85.00% |
| 2021 | 833.09 | -16.14% |
| 2020 | 993.40 | 130.30% |
| 2019 | 431.35 | 103.35% |
| 2018 | 212.13 | -70.89% |
| 2017 | 728.64 | 557.34% |
| 2016 | 110.85 | 125.22% |
| 2015 | 49.22 | 161.17% |
| 2014 | 18.84 | 160.08% |
| 2013 | 7.25 | -26.75% |
| 2012 | 9.89 | 0.00% |
| 2011 | 0.00 | 0.00% |
Δείκτης P/S για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | P/S Ratio | Διαφορά P/S Ratio | Χώρα |
|---|---|---|---|
| 10.02 | -16.00% |
US
|
|
| 40.55 | 239.89% |
US
|
|
| 3.96 | -66.80% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -14.96% |
NL
|
